25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Ocugen Inc
Buy, Hold or Sell?

Let's analyze Ocugen together

I guess you are interested in Ocugen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ocugen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Ocugen Inc

I send you an email if I find something interesting about Ocugen Inc.

1. Quick Overview

1.1. Quick analysis of Ocugen (30 sec.)










1.2. What can you expect buying and holding a share of Ocugen? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.06
Expected worth in 1 year
$-0.13
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.19
Return On Investment
-19.5%

For what price can you sell your share?

Current Price per Share
$0.95
Expected price per share
$0.778 - $1.12
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ocugen (5 min.)




Live pricePrice per Share (EOD)
$0.95
Intrinsic Value Per Share
$-1.82 - $1.22
Total Value Per Share
$-1.76 - $1.27

2.2. Growth of Ocugen (5 min.)




Is Ocugen growing?

Current yearPrevious yearGrowGrow %
How rich?$16.9m$81.3m-$44.8m-122.7%

How much money is Ocugen making?

Current yearPrevious yearGrowGrow %
Making money-$12.7m-$19.6m$6.9m54.6%
Net Profit Margin-668.1%-1,058.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Ocugen (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#571 / 960

Most Revenue
#446 / 960

Most Profit
#601 / 960

Most Efficient
#680 / 960
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ocugen?

Welcome investor! Ocugen's management wants to use your money to grow the business. In return you get a share of Ocugen.

First you should know what it really means to hold a share of Ocugen. And how you can make/lose money.

Speculation

The Price per Share of Ocugen is $0.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ocugen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ocugen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.06. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ocugen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.05-5.6%-0.04-4.6%-0.07-7.6%-0.05-5.0%-0.03-3.4%
Usd Book Value Change Per Share-0.05-4.9%-0.05-4.9%-0.04-4.0%0.000.5%0.011.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-4.9%-0.05-4.9%-0.04-3.9%0.000.5%0.011.0%
Usd Price Per Share1.55-1.04-1.12-2.34-2.61-
Price to Earnings Ratio-7.30--5.90--3.88--13.57-3.49-
Price-to-Total Gains Ratio-33.46--24.56--30.42--51.12--85.17-
Price to Book Ratio26.36-12.00-3.82-8.41-27.82-
Price-to-Total Gains Ratio-33.46--24.56--30.42--51.12--85.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.95
Number of shares1052
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.00
Usd Total Gains Per Share-0.050.00
Gains per Quarter (1052 shares)-48.754.85
Gains per Year (1052 shares)-194.9919.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-195-2051199
20-390-40013828
30-585-59525647
40-780-79037566
50-975-98539485
60-1170-11804113104
70-1365-13755131123
80-1560-15705150142
90-1755-17656169161
100-1950-19606188180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%4.036.00.010.0%4.040.00.09.1%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%6.014.00.030.0%11.029.00.027.5%11.031.02.025.0%
Dividend per Share0.00.04.00.0%2.00.010.016.7%2.00.018.010.0%2.00.038.05.0%2.00.042.04.5%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%6.014.00.030.0%11.029.00.027.5%11.031.02.025.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Ocugen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.046-0.046+0%-0.038-18%0.004-1139%0.009-596%
Book Value Per Share--0.0590.127-54%0.283-79%0.198-70%0.116-49%
Current Ratio--1.0362.625-61%5.846-82%7.822-87%6.040-83%
Debt To Asset Ratio--0.5820.397+47%0.207+181%0.309+88%0.689-16%
Debt To Equity Ratio--1.3950.744+87%0.262+432%0.360+288%1.310+6%
Dividend Per Share----0%0.001-100%0.000-100%0.000-100%
Eps---0.053-0.044-17%-0.072+36%-0.048-10%-0.033-39%
Free Cash Flow Per Share---0.036-0.047+31%-0.066+81%-0.040+10%-0.031-16%
Free Cash Flow To Equity Per Share---0.036-0.047+31%-0.040+10%0.005-807%0.002-1851%
Gross Profit Margin--1.0381.013+2%1.000+4%1.003+4%1.001+4%
Intrinsic Value_10Y_max--1.216--------
Intrinsic Value_10Y_min---1.821--------
Intrinsic Value_1Y_max---0.087--------
Intrinsic Value_1Y_min---0.207--------
Intrinsic Value_3Y_max---0.102--------
Intrinsic Value_3Y_min---0.604--------
Intrinsic Value_5Y_max--0.075--------
Intrinsic Value_5Y_min---0.980--------
Market Cap273465084.800-63%446179875.200299732125.840+49%322113084.096+39%673184681.382-34%750776800.970-41%
Net Profit Margin---13.392-6.681-50%-10.586-21%-32127.488+239805%-16063.744+119852%
Operating Margin---13.540-6.748-50%-12.647-7%-32604.628+240704%-16302.314+120302%
Operating Ratio--14.5407.511+94%12.647+15%32629.377-100%16314.688-100%
Pb Ratio16.156-63%26.35912.003+120%3.823+589%8.406+214%27.825-5%
Pe Ratio-4.474+39%-7.300-5.897-19%-3.883-47%-13.574+86%3.494-309%
Price Per Share0.950-63%1.5501.041+49%1.119+39%2.339-34%2.608-41%
Price To Free Cash Flow Ratio-6.559+39%-10.701-6.113-43%-4.575-57%-13.087+22%-18.148+70%
Price To Total Gains Ratio-20.509+39%-33.462-24.563-27%-30.417-9%-51.120+53%-85.165+155%
Quick Ratio--0.8732.407-64%5.785-85%7.102-88%5.773-85%
Return On Assets---0.377-0.236-37%-0.194-49%-0.196-48%-0.233-38%
Return On Equity---0.903-0.443-51%-0.245-73%-0.213-76%-0.496-45%
Total Gains Per Share---0.046-0.046+0%-0.037-19%0.005-1105%0.009-592%
Usd Book Value--16927000.00036536750.000-54%81359000.000-79%56923168.350-70%33275909.175-49%
Usd Book Value Change Per Share---0.046-0.046+0%-0.038-18%0.004-1139%0.009-596%
Usd Book Value Per Share--0.0590.127-54%0.283-79%0.198-70%0.116-49%
Usd Dividend Per Share----0%0.001-100%0.000-100%0.000-100%
Usd Eps---0.053-0.044-17%-0.072+36%-0.048-10%-0.033-39%
Usd Free Cash Flow---10424000.000-13616500.000+31%-18879750.000+81%-11485314.100+10%-8786258.725-16%
Usd Free Cash Flow Per Share---0.036-0.047+31%-0.066+81%-0.040+10%-0.031-16%
Usd Free Cash Flow To Equity Per Share---0.036-0.047+31%-0.040+10%0.005-807%0.002-1851%
Usd Market Cap273465084.800-63%446179875.200299732125.840+49%322113084.096+39%673184681.382-34%750776800.970-41%
Usd Price Per Share0.950-63%1.5501.041+49%1.119+39%2.339-34%2.608-41%
Usd Profit---15280000.000-12714750.000-17%-19655750.000+29%-12872058.350-16%-9114254.175-40%
Usd Revenue--1141000.0002047750.000-44%732750.000+56%2687664.396-58%1343832.198-15%
Usd Total Gains Per Share---0.046-0.046+0%-0.037-19%0.005-1105%0.009-592%
 EOD+3 -5MRQTTM+15 -19YOY+15 -215Y+9 -2710Y+9 -27

3.3 Fundamental Score

Let's check the fundamental score of Ocugen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.474
Price to Book Ratio (EOD)Between0-116.156
Net Profit Margin (MRQ)Greater than0-13.392
Operating Margin (MRQ)Greater than0-13.540
Quick Ratio (MRQ)Greater than10.873
Current Ratio (MRQ)Greater than11.036
Debt to Asset Ratio (MRQ)Less than10.582
Debt to Equity Ratio (MRQ)Less than11.395
Return on Equity (MRQ)Greater than0.15-0.903
Return on Assets (MRQ)Greater than0.05-0.377
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Ocugen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.929
Ma 20Greater thanMa 501.113
Ma 50Greater thanMa 1001.249
Ma 100Greater thanMa 2001.453
OpenGreater thanClose1.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.

Fundamental data was last updated by Penke on 2024-09-12 06:52:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Ocugen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • A Net Profit Margin of -1,339.2% means that $-13.39 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ocugen Inc:

  • The MRQ is -1,339.2%. The company is making a huge loss. -2
  • The TTM is -668.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,339.2%TTM-668.1%-671.1%
TTM-668.1%YOY-1,058.6%+390.5%
TTM-668.1%5Y-3,212,748.8%+3,212,080.7%
5Y-3,212,748.8%10Y-1,606,374.4%-1,606,374.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,339.2%-126.1%-1,213.1%
TTM-668.1%-194.5%-473.6%
YOY-1,058.6%-207.8%-850.8%
5Y-3,212,748.8%-373.2%-3,212,375.6%
10Y-1,606,374.4%-473.1%-1,605,901.3%
4.3.1.2. Return on Assets

Shows how efficient Ocugen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • -37.7% Return on Assets means that Ocugen generated $-0.38 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ocugen Inc:

  • The MRQ is -37.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-37.7%TTM-23.6%-14.1%
TTM-23.6%YOY-19.4%-4.2%
TTM-23.6%5Y-19.6%-4.0%
5Y-19.6%10Y-23.3%+3.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.7%-11.1%-26.6%
TTM-23.6%-11.9%-11.7%
YOY-19.4%-11.3%-8.1%
5Y-19.6%-13.2%-6.4%
10Y-23.3%-14.9%-8.4%
4.3.1.3. Return on Equity

Shows how efficient Ocugen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • -90.3% Return on Equity means Ocugen generated $-0.90 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ocugen Inc:

  • The MRQ is -90.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -44.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-90.3%TTM-44.3%-45.9%
TTM-44.3%YOY-24.5%-19.8%
TTM-44.3%5Y-21.3%-23.1%
5Y-21.3%10Y-49.6%+28.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-90.3%-14.2%-76.1%
TTM-44.3%-16.0%-28.3%
YOY-24.5%-13.8%-10.7%
5Y-21.3%-19.1%-2.2%
10Y-49.6%-19.8%-29.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Ocugen Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Ocugen is operating .

  • Measures how much profit Ocugen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • An Operating Margin of -1,354.0% means the company generated $-13.54  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ocugen Inc:

  • The MRQ is -1,354.0%. The company is operating very inefficient. -2
  • The TTM is -674.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,354.0%TTM-674.8%-679.2%
TTM-674.8%YOY-1,264.7%+589.8%
TTM-674.8%5Y-3,260,462.8%+3,259,788.0%
5Y-3,260,462.8%10Y-1,630,231.4%-1,630,231.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,354.0%-279.4%-1,074.6%
TTM-674.8%-329.9%-344.9%
YOY-1,264.7%-230.4%-1,034.3%
5Y-3,260,462.8%-391.8%-3,260,071.0%
10Y-1,630,231.4%-499.6%-1,629,731.8%
4.3.2.2. Operating Ratio

Measures how efficient Ocugen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 14.54 means that the operating costs are $14.54 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ocugen Inc:

  • The MRQ is 14.540. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.511. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.540TTM7.511+7.029
TTM7.511YOY12.647-5.135
TTM7.5115Y32,629.377-32,621.866
5Y32,629.37710Y16,314.688+16,314.688
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.5402.759+11.781
TTM7.5113.146+4.365
YOY12.6473.336+9.311
5Y32,629.3775.133+32,624.244
10Y16,314.6886.571+16,308.117
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Ocugen Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ocugen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.04 means the company has $1.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ocugen Inc:

  • The MRQ is 1.036. The company is just able to pay all its short-term debts.
  • The TTM is 2.625. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.036TTM2.625-1.589
TTM2.625YOY5.846-3.222
TTM2.6255Y7.822-5.197
5Y7.82210Y6.040+1.781
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0363.806-2.770
TTM2.6254.010-1.385
YOY5.8464.719+1.127
5Y7.8225.980+1.842
10Y6.0406.318-0.278
4.4.3.2. Quick Ratio

Measures if Ocugen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • A Quick Ratio of 0.87 means the company can pay off $0.87 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ocugen Inc:

  • The MRQ is 0.873. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.407. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.873TTM2.407-1.534
TTM2.407YOY5.785-3.378
TTM2.4075Y7.102-4.695
5Y7.10210Y5.773+1.329
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8733.346-2.473
TTM2.4073.567-1.160
YOY5.7854.698+1.087
5Y7.1025.910+1.192
10Y5.7736.500-0.727
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Ocugen Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Ocugen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ocugen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.58 means that Ocugen assets are financed with 58.2% credit (debt) and the remaining percentage (100% - 58.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ocugen Inc:

  • The MRQ is 0.582. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.397. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.582TTM0.397+0.186
TTM0.397YOY0.207+0.190
TTM0.3975Y0.309+0.088
5Y0.30910Y0.689-0.380
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5820.342+0.240
TTM0.3970.344+0.053
YOY0.2070.309-0.102
5Y0.3090.365-0.056
10Y0.6890.384+0.305
4.5.4.2. Debt to Equity Ratio

Measures if Ocugen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ocugen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 139.5% means that company has $1.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ocugen Inc:

  • The MRQ is 1.395. The company is able to pay all its debts with equity. +1
  • The TTM is 0.744. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.395TTM0.744+0.651
TTM0.744YOY0.262+0.482
TTM0.7445Y0.360+0.385
5Y0.36010Y1.310-0.951
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3950.393+1.002
TTM0.7440.439+0.305
YOY0.2620.372-0.110
5Y0.3600.448-0.088
10Y1.3100.489+0.821
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ocugen generates.

  • Above 15 is considered overpriced but always compare Ocugen to the Biotechnology industry mean.
  • A PE ratio of -7.30 means the investor is paying $-7.30 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ocugen Inc:

  • The EOD is -4.474. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.300. Based on the earnings, the company is expensive. -2
  • The TTM is -5.897. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.474MRQ-7.300+2.826
MRQ-7.300TTM-5.897-1.403
TTM-5.897YOY-3.883-2.014
TTM-5.8975Y-13.574+7.676
5Y-13.57410Y3.494-17.067
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.474-2.310-2.164
MRQ-7.300-2.379-4.921
TTM-5.897-2.921-2.976
YOY-3.883-3.405-0.478
5Y-13.574-6.019-7.555
10Y3.494-6.254+9.748
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ocugen Inc:

  • The EOD is -6.559. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.701. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.113. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.559MRQ-10.701+4.142
MRQ-10.701TTM-6.113-4.587
TTM-6.113YOY-4.575-1.538
TTM-6.1135Y-13.087+6.973
5Y-13.08710Y-18.148+5.061
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.559-2.954-3.605
MRQ-10.701-3.175-7.526
TTM-6.113-3.483-2.630
YOY-4.575-4.594+0.019
5Y-13.087-8.064-5.023
10Y-18.148-8.708-9.440
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Ocugen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 26.36 means the investor is paying $26.36 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ocugen Inc:

  • The EOD is 16.156. Based on the equity, the company is expensive. -2
  • The MRQ is 26.359. Based on the equity, the company is expensive. -2
  • The TTM is 12.003. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD16.156MRQ26.359-10.204
MRQ26.359TTM12.003+14.356
TTM12.003YOY3.823+8.180
TTM12.0035Y8.406+3.597
5Y8.40610Y27.825-19.419
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD16.1561.886+14.270
MRQ26.3591.972+24.387
TTM12.0032.201+9.802
YOY3.8232.363+1.460
5Y8.4063.551+4.855
10Y27.8254.200+23.625
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ocugen Inc.

4.8.1. Institutions holding Ocugen Inc

Institutions are holding 23.519% of the shares of Ocugen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc6.22540.00061792018714120947371.6782
2024-06-30Vanguard Group Inc5.3920.000515521167352161629.3479
2024-06-30State Street Corp5.13330.00114776621138198951444.4987
2024-06-30Geode Capital Management, LLC2.05140.00085904999269147983.7549
2024-06-30Rafferty Asset Management, LLC0.37420.0062107704210770420
2024-06-30CI Private Wealth LLC0.31270.00249001309001300
2024-06-30Charles Schwab Investment Management Inc0.26960.0002776016605762355.799
2024-06-30Goldman Sachs Group Inc0.26380.0002759440-1848185-70.8762
2024-06-30Nuveen Asset Management, LLC0.2630.00037569267569260
2024-06-30Bank of New York Mellon Corp0.26120.00027518197255362760.4764
2024-06-30Group One Trading, LP0.22630.0039651381265854.255
2024-06-30Bank of America Corp0.22270.0001641071367288134.153
2024-06-30Susquehanna International Group, LLP0.22260.0002640745-556354-46.4752
2024-06-30Northern Trust Corp0.21680.000262400711469022.5184
2024-03-31Morgan Stanley - Brokerage Accounts0.21520.0001619405323236109.139
2024-03-31JPMorgan Chase & Co0.13620.0001391925209112114.3857
2024-06-30Two Sigma Investments LLC0.12630.0013363483-662525-64.5731
2024-06-30Rhumbline Advisers0.10460.00043012182916253039.9771
2024-06-30T. Rowe Price Associates, Inc.0.09340.00012688208172043.6772
2024-06-30Alpine Partners VI, LLC0.08420.06532423112423110
Total 22.19490.084163888713+36808836+57.6%

4.9.2. Funds holding Ocugen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-08-30SPDR® S&P Biotech ETF3.02120.14018696754301070.3474
2024-07-31Vanguard Total Stock Mkt Idx Inv2.9160.0007839378900
2024-08-30iShares Russell 2000 ETF2.40360.01266919056437880.6369
2024-07-31Vanguard Institutional Extnd Mkt Idx Tr1.3970.00524021269259090.6485
2024-08-30iShares Russell 2000 Growth ETF0.78710.0252265716-2697-0.1189
2024-07-31State St Russell Sm/Mid Cp® Indx NL Cl C0.71040.0062204494719719002699.4948
2024-07-31Fidelity Extended Market Index0.52050.00511498328297812.0279
2024-08-30SPDR® S&P Kensho New Economies Comps ETF0.44650.084128521400
2024-07-31State St Russell Sm Cap® Indx SL Cl I0.36180.0141104160000
2024-07-31Vanguard Russell 2000 ETF0.34910.0131004824522165.4814
2024-07-31Vanguard Health Care ETF0.3020.0058869392-4480-0.5127
2024-08-29Direxion Daily S&P Biotech Bull 3X ETF0.24560.085370694600
2024-07-31Schwab Small Cap Index0.2170.0135624606195823.2366
2024-08-30iShares Micro-Cap ETF0.20720.084959652200
2024-06-30BlackRock Extended Equity Market K0.18030.0058518909-500-0.0963
2024-07-31iShares Russell 2000 Small-Cap Idx Instl0.17720.013351018400
2024-06-30Russell 2000 Index Non-Lendable Fund E0.17570.01575057255057250
2024-07-31Fidelity Total Market Index0.15960.0007459470-611-0.1328
2024-06-30BlackRock Russell 2500™ Index F0.14540.00694184934184930
2024-08-30iShares Core S&P Total US Stock Mkt ETF0.12390.000835663400
Total 14.84710.538742738378+3089213+7.2%

5.3. Insider Transactions

Insiders are holding 1.414% of the shares of Ocugen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-14Junge ZhangBUY2002780.5
2023-01-17Shankar MusunuriSELL1000001.28
2022-10-14Shankar MusunuriSELL1000001.66
2022-10-06Ramesh KumarSELL45001.83
2022-08-11Kirsten CastilloSELL420002.91
2022-07-18Ramesh KumarSELL75002.57
2022-07-14Shankar MusunuriSELL1500002.72
2022-05-13Shankar MusunuriSELL1250001.92
2022-04-18Ramesh KumarSELL75002.83
2022-03-16Shankar MusunuriSELL818232.65
2022-01-18Ramesh KumarSELL75004.07
2021-12-16Shankar MusunuriSELL1150005.22
2021-11-16Shankar MusunuriSELL1150008.04
2021-11-03Junge ZhangSELL15030017.32
2021-11-01Shankar MusunuriSELL11536714.15
2021-11-01Uday KompellaSELL2500014.05
2021-10-26Sanjay SubramanianSELL1000011.07
2021-10-25Uday KompellaSELL463719.08
2021-10-20Uday KompellaSELL17319.02
2021-10-18Uday KompellaSELL2000008.41
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets40,542
Total Liabilities23,615
Total Stockholder Equity16,927
 As reported
Total Liabilities 23,615
Total Stockholder Equity+ 16,927
Total Assets = 40,542

Assets

Total Assets40,542
Total Current Assets18,617
Long-term Assets21,925
Total Current Assets
Cash And Cash Equivalents 15,697
Other Current Assets 2,920
Total Current Assets  (as reported)18,617
Total Current Assets  (calculated)18,617
+/-0
Long-term Assets
Property Plant Equipment 17,474
Long-term Assets Other 4,149
Long-term Assets  (as reported)21,925
Long-term Assets  (calculated)21,623
+/- 302

Liabilities & Shareholders' Equity

Total Current Liabilities17,972
Long-term Liabilities5,643
Total Stockholder Equity16,927
Total Current Liabilities
Short-term Debt 1,767
Short Long Term Debt 1,306
Accounts payable 3,391
Other Current Liabilities 4,034
Total Current Liabilities  (as reported)17,972
Total Current Liabilities  (calculated)10,498
+/- 7,474
Long-term Liabilities
Long term Debt 1,552
Capital Lease Obligations 4,007
Long-term Liabilities Other 545
Long-term Liabilities  (as reported)5,643
Long-term Liabilities  (calculated)6,104
+/- 461
Total Stockholder Equity
Common Stock2,576
Retained Earnings -313,371
Accumulated Other Comprehensive Income 28
Other Stockholders Equity 327,694
Total Stockholder Equity (as reported)16,927
Total Stockholder Equity (calculated)16,927
+/-0
Other
Capital Stock2,576
Cash and Short Term Investments 15,697
Common Stock Shares Outstanding 257,354
Current Deferred Revenue8,780
Liabilities and Stockholders Equity 40,542
Net Debt -8,832
Net Invested Capital 19,785
Net Working Capital 645
Property Plant and Equipment Gross 19,440
Short Long Term Debt Total 6,865



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
> Total Assets 
0
14,796
0
14,844
12,995
65,499
61,580
53,238
45,301
36,786
28,515
21,278
42,795
36,078
28,310
22,127
15,828
11,035
21,325
15,151
10,881
17,428
14,838
3,200
23,619
16,807
12,314
23,759
20,540
27,376
53,847
124,251
116,312
105,761
141,727
130,088
116,239
108,632
96,299
88,976
74,687
64,547
51,794
40,542
40,54251,79464,54774,68788,97696,299108,632116,239130,088141,727105,761116,312124,25153,84727,37620,54023,75912,31416,80723,6193,20014,83817,42810,88115,15121,32511,03515,82822,12728,31036,07842,79521,27828,51536,78645,30153,23861,58065,49912,99514,844014,7960
   > Total Current Assets 
0
10,346
0
10,377
7,371
58,856
54,010
46,119
38,088
31,236
23,363
16,276
38,195
32,081
24,670
18,844
12,877
8,175
16,365
9,653
6,017
16,400
8,140
3,200
22,819
15,766
11,362
22,893
19,759
25,878
51,356
121,626
113,450
102,646
138,027
122,569
107,497
98,492
84,401
73,452
56,558
42,971
29,998
18,617
18,61729,99842,97156,55873,45284,40198,492107,497122,569138,027102,646113,450121,62651,35625,87819,75922,89311,36215,76622,8193,2008,14016,4006,0179,65316,3658,17512,87718,84424,67032,08138,19516,27623,36331,23638,08846,11954,01058,8567,37110,377010,3460
       Cash And Cash Equivalents 
0
8,734
0
7,776
4,258
58,060
53,181
45,222
37,723
30,915
22,897
15,926
37,994
31,908
16,374
10,562
10,798
7,081
15,507
8,772
5,192
15,542
7,376
2,786
15,301
7,444
3,193
14,968
19,106
24,039
44,792
115,642
107,349
94,958
129,771
115,005
101,602
77,563
68,259
70,578
53,477
39,462
26,375
15,697
15,69726,37539,46253,47770,57868,25977,563101,602115,005129,77194,958107,349115,64244,79224,03919,10614,9683,1937,44415,3012,7867,37615,5425,1928,77215,5077,08110,79810,56216,37431,90837,99415,92622,89730,91537,72345,22253,18158,0604,2587,77608,7340
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,000
7,978
1,821
900
12,403
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,371
8,462
0
0
0
0
0
000008,46213,37100000000000000000012,4039001,8217,9788,00000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,988
0
4,988
0
0
0
0
0
0
0
0
0
0
00000000004,9880-4,9880000000000000000000000000000000
       Other Current Assets 
0
33
0
31
78
146
829
897
365
195
466
350
201
68
296
304
258
112
858
881
825
172
764
414
7,518
8,322
8,169
7,925
653
1,838
6,564
5,984
6,101
7,688
8,256
7,564
5,895
7,558
7,680
2,874
3,081
3,509
3,623
2,920
2,9203,6233,5093,0812,8747,6807,5585,8957,5648,2567,6886,1015,9846,5641,8386537,9258,1698,3227,5184147641728258818581122583042966820135046619536589782914678310330
   > Long-term Assets 
0
4,450
0
4,467
5,624
6,643
7,570
7,119
7,213
5,550
5,152
5,002
4,600
3,997
3,640
3,283
2,951
2,860
4,960
5,498
4,864
1,028
6,698
875
800
1,041
951
866
781
1,499
2,491
2,625
2,862
3,115
3,700
7,519
8,742
10,140
11,898
15,524
18,129
21,576
21,796
21,925
21,92521,79621,57618,12915,52411,89810,1408,7427,5193,7003,1152,8622,6252,4911,4997818669511,0418008756,6981,0284,8645,4984,9602,8602,9513,2833,6403,9974,6005,0025,1525,5507,2137,1197,5706,6435,6244,46704,4500
       Property Plant Equipment 
0
2,283
0
2,163
3,378
4,878
5,422
5,428
5,513
5,213
4,815
4,665
4,263
3,860
3,503
3,146
2,814
2,723
4,448
5,173
4,352
141
135
653
213
222
249
232
214
633
762
944
1,052
1,164
1,921
3,153
4,517
6,053
7,952
11,720
14,469
17,290
17,654
17,474
17,47417,65417,29014,46911,7207,9526,0534,5173,1531,9211,1641,0529447626332142322492222136531351414,3525,1734,4482,7232,8143,1463,5033,8604,2634,6654,8155,2135,5135,4285,4224,8783,3782,16302,2830
       Intangible Assets 
0
570
0
570
570
510
510
510
510
200
200
200
200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000020020020020051051051051057057005700
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
887
137
222
202
474
399
373
349
432
1,729
201
380
1,951
355
0
185
177
0
0
0
0
0
0
00000017718503551,9513802011,729432349373399474202222137887000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
1,034
1,044
1,053
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000001,0531,0441,034000000
> Total Liabilities 
0
90,350
0
105,444
8,967
11,293
10,356
9,373
9,125
8,588
7,923
8,389
38,759
22,511
21,338
21,321
20,641
22,303
41,395
38,589
20,557
17,886
20,370
11,931
36,712
5,789
5,017
9,136
6,118
5,826
7,358
7,842
9,202
9,943
10,598
15,980
20,936
24,580
20,499
18,695
16,292
23,983
21,533
23,615
23,61521,53323,98316,29218,69520,49924,58020,93615,98010,5989,9439,2027,8427,3585,8266,1189,1365,0175,78936,71211,93120,37017,88620,55738,58941,39522,30320,64121,32121,33822,51138,7598,3897,9238,5889,1259,37310,35611,2938,967105,444090,3500
   > Total Current Liabilities 
0
5,087
0
6,059
7,579
8,251
7,499
6,687
6,690
6,359
5,975
6,721
7,209
5,171
3,895
3,827
2,914
3,805
8,420
11,657
8,943
2,873
2,317
791
35,413
4,544
3,315
7,041
4,131
3,614
4,281
4,840
6,229
7,000
7,687
10,338
14,907
18,460
15,683
13,460
11,136
17,089
16,050
17,972
17,97216,05017,08911,13613,46015,68318,46014,90710,3387,6877,0006,2294,8404,2813,6144,1317,0413,3154,54435,4137912,3172,8738,94311,6578,4203,8052,9143,8273,8955,1717,2096,7215,9756,3596,6906,6877,4998,2517,5796,05905,0870
       Short-term Debt 
0
0
0
0
90
405
538
583
583
583
583
583
583
583
570
470
324
178
45
0
0
8,868
1,118
10,000
171
172
177
4,244
1,375
278
538
168
172
363
254
314
443
498
1,768
1,792
1,816
574
1,885
1,767
1,7671,8855741,8161,7921,7684984433142543631721685382781,3754,24417717217110,0001,1188,8680045178324470570583583583583583583583538405900000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,068
1,211
234
374
0
0
0
0
0
0
0
1,256
1,266
1,276
0
1,296
1,306
1,3061,29601,2761,2661,25600000003742341,2114,068000000000000000000000000000
       Accounts payable 
0
2,530
0
2,851
4,358
4,886
3,293
2,337
2,001
2,253
1,973
2,038
1,800
1,948
1,887
1,618
827
776
1,362
2,207
1,690
1,590
1,100
538
5,791
1,896
1,548
508
222
395
1,040
802
2,095
2,312
3,896
5,921
6,460
8,062
8,092
3,881
2,921
3,172
1,731
3,391
3,3911,7313,1722,9213,8818,0928,0626,4605,9213,8962,3122,0958021,0403952225081,5481,8965,7915381,1001,5901,6902,2071,3627768271,6181,8871,9481,8002,0381,9732,2532,0012,3373,2934,8864,3582,85102,5300
       Other Current Liabilities 
0
2,557
0
3,208
109
125
3,668
3,767
4,106
548
3,419
4,100
4,826
508
1,438
1,739
1,763
835
2,013
1,950
2,253
151
-9,901
253
27,965
206
206
205
199
10
134
199
422
293
3,537
4,103
8,004
-1,321
5,823
7,787
1,515
2,818
2,822
4,034
4,0342,8222,8181,5157,7875,823-1,3218,0044,1033,5372934221991341019920520620627,965253-9,9011512,2531,9502,0138351,7631,7391,4385084,8264,1003,4195484,1063,7673,6681251093,20802,5570
   > Long-term Liabilities 
0
85,263
0
99,385
1,388
3,042
2,857
2,686
2,435
2,229
1,948
1,668
31,550
17,340
17,443
17,494
17,727
18,498
32,975
26,932
11,614
15,013
18,053
11,140
1,299
1,245
1,702
2,095
1,987
2,212
3,077
3,002
2,973
2,943
2,911
5,642
6,029
6,120
4,816
5,235
5,156
6,894
5,483
5,643
5,6435,4836,8945,1565,2354,8166,1206,0295,6422,9112,9432,9733,0023,0772,2121,9872,0951,7021,2451,29911,14018,05315,01311,61426,93232,97518,49817,72717,49417,44317,34031,5501,6681,9482,2292,4352,6862,8573,0421,38899,385085,2630
       Long term Debt Total 
0
0
0
0
0
0
1,199
1,053
907
761
615
470
324
178
45
0
0
0
0
0
0
0
0
0
1,058
1,072
1,581
2,019
1,944
1,823
1,702
1,674
1,693
1,712
1,731
1,750
2,265
0
1,058
1,472
0
0
0
0
00001,4721,05802,2651,7501,7311,7121,6931,6741,7021,8231,9442,0191,5811,0721,058000000000451783244706157619071,0531,199000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
1,034
1,044
1,053
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000001,0531,0441,034000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
0
0
0
0
0
0
0
0
0
0
244
0
0
0
0
0
0
0000002440000000000120000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
1,658
1,633
1,528
1,468
1,333
1,198
1,061
925
891
853
816
779
6,503
1,461
1,419
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001,4191,4616,5037798168538919251,0611,1981,3331,4681,5281,6331,658000000
> Total Stockholder Equity
0
-75,554
0
-90,600
4,028
54,206
51,224
43,865
36,176
28,198
20,592
12,889
4,036
13,567
6,972
806
-4,813
-11,268
-20,070
-23,438
-9,676
-458
-5,532
-8,731
-13,093
11,018
7,297
14,623
14,422
21,550
46,489
116,409
107,110
95,818
131,129
114,108
95,303
84,052
75,800
70,281
58,395
40,564
30,261
16,927
16,92730,26140,56458,39570,28175,80084,05295,303114,108131,12995,818107,110116,40946,48921,55014,42214,6237,29711,018-13,093-8,731-5,532-458-9,676-23,438-20,070-11,268-4,8138066,97213,5674,03612,88920,59228,19836,17643,86551,22454,2064,028-90,6000-75,5540
   Common Stock
0
6
0
6
7
127
132
132
132
132
133
133
159
159
159
159
159
159
186
186
221
513
839
839
100
527
527
1,351
1,621
1,841
1,883
1,988
1,990
1,995
2,158
2,163
2,168
2,217
2,265
2,566
2,566
2,567
2,575
2,576
2,5762,5752,5672,5662,5662,2652,2172,1682,1632,1581,9951,9901,9881,8831,8411,6211,35152752710083983951322118618615915915915915915913313313213213213212776060
   Retained Earnings Total Equity
0
0
0
0
0
0
-141,505
-149,138
-157,216
-165,565
-173,483
-181,521
-190,836
-181,773
-188,854
-195,396
-201,391
-208,187
-223,020
-226,797
-216,012
0
-226,245
-229,481
-63,862
51,480
-55,424
-59,038
-69,511
-73,302
-80,379
-106,331
-117,086
-131,667
-149,686
-169,157
-191,079
0
-229,516
-252,441
0
0
0
0
0000-252,441-229,5160-191,079-169,157-149,686-131,667-117,086-106,331-80,379-73,302-69,511-59,038-55,42451,480-63,862-229,481-226,2450-216,012-226,797-223,020-208,187-201,391-195,396-188,854-181,773-190,836-181,521-173,483-165,565-157,216-149,138-141,505000000
   Accumulated Other Comprehensive Income 
0
-5,649
0
-5,963
-6,132
-6,375
-6,747
-7,143
-7,557
-7,989
-8,419
-8,851
-9,256
-9,387
-6
-2
-10,563
-10,919
-11,091
-11,239
-11,280
-10,286
-10,113
0
0
0
0
0
0
0
-226
-275
0
0
0
10
30
26
25
22
27
20
25
28
282520272225263010000-275-2260000000-10,113-10,286-11,280-11,239-11,091-10,919-10,563-2-6-9,387-9,256-8,851-8,419-7,989-7,557-7,143-6,747-6,375-6,132-5,9630-5,6490
   Capital Surplus 
0
0
0
0
0
0
192,597
192,871
193,260
193,631
193,942
194,277
194,713
195,181
195,673
196,045
196,419
196,760
202,764
203,173
206,115
215,859
219,874
219,911
50,668
62,019
62,241
72,357
82,359
93,059
125,032
220,799
222,253
225,537
278,704
281,139
284,231
0
303,073
320,181
0
0
0
0
0000320,181303,0730284,231281,139278,704225,537222,253220,799125,03293,05982,35972,35762,24162,01950,668219,911219,874215,859206,115203,173202,764196,760196,419196,045195,673195,181194,713194,277193,942193,631193,260192,871192,597000000
   Treasury Stock0000-48-480-48-48-48-48-48-48-48-48-48-48-48-480000000000000000000000000
   Other Stockholders Equity 
0
40,837
0
37,844
120,766
193,995
199,344
200,014
200,817
201,620
202,361
203,128
203,969
204,568
195,673
196,045
206,982
207,679
213,855
214,412
217,395
226,145
229,987
219,911
50,668
61,971
62,193
72,309
82,312
93,011
125,210
221,026
222,205
225,489
278,656
281,091
284,183
294,826
303,025
320,133
322,404
324,143
325,751
327,694
327,694325,751324,143322,404320,133303,025294,826284,183281,091278,656225,489222,205221,026125,21093,01182,31272,30962,19361,97150,668219,911229,987226,145217,395214,412213,855207,679206,982196,045195,673204,568203,969203,128202,361201,620200,817200,014199,344193,995120,76637,844040,8370



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue6,036
Cost of Revenue-704
Gross Profit5,3325,332
 
Operating Income (+$)
Gross Profit5,332
Operating Expense-71,567
Operating Income-65,531-66,235
 
Operating Expense (+$)
Research Development39,573
Selling General Administrative31,994
Selling And Marketing Expenses0
Operating Expense71,56771,567
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-65,531
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-63,078-67,984
EBIT - interestExpense = -65,531
-62,542
-63,078
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-65,531-63,078
Earnings Before Interest and Taxes (EBITDA)-64,827
 
After tax Income (+$)
Income Before Tax-63,078
Tax Provision-0
Net Income From Continuing Ops-63,078-63,078
Net Income-63,078
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses71,567
Total Other Income/Expenses Net2,4530
 

Technical Analysis of Ocugen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ocugen. The general trend of Ocugen is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ocugen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ocugen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.08 < 1.11 < 1.12.

The bearish price targets are: 0.9359 > 0.802 > 0.778.

Tweet this
Ocugen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ocugen Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ocugen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ocugen Inc. The current macd is -0.08361646.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ocugen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ocugen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ocugen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ocugen Inc Daily Moving Average Convergence/Divergence (MACD) ChartOcugen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ocugen Inc. The current adx is 42.96.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ocugen shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Ocugen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ocugen Inc. The current sar is 1.06495572.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ocugen Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ocugen Inc. The current rsi is 32.93. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Ocugen Inc Daily Relative Strength Index (RSI) ChartOcugen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ocugen Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ocugen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ocugen Inc Daily Stochastic Oscillator ChartOcugen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ocugen Inc. The current cci is -131.50572667.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Ocugen Inc Daily Commodity Channel Index (CCI) ChartOcugen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ocugen Inc. The current cmo is -41.12704395.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ocugen Inc Daily Chande Momentum Oscillator (CMO) ChartOcugen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ocugen Inc. The current willr is -95.36336731.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Ocugen Inc Daily Williams %R ChartOcugen Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ocugen Inc.

Ocugen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ocugen Inc. The current atr is 0.07724101.

Ocugen Inc Daily Average True Range (ATR) ChartOcugen Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ocugen Inc. The current obv is 17,601,630.

Ocugen Inc Daily On-Balance Volume (OBV) ChartOcugen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ocugen Inc. The current mfi is 14.72.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Ocugen Inc Daily Money Flow Index (MFI) ChartOcugen Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ocugen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-05-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-05-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Ocugen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ocugen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.929
Ma 20Greater thanMa 501.113
Ma 50Greater thanMa 1001.249
Ma 100Greater thanMa 2001.453
OpenGreater thanClose1.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ocugen with someone you think should read this too:
  • Are you bullish or bearish on Ocugen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ocugen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ocugen Inc

I send you an email if I find something interesting about Ocugen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ocugen Inc.

Receive notifications about Ocugen Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.